Tadiometer (Seca Leicester; Hamburg, Germany). We also measured mid-upper arm circumference and tricipital skinfold of the non-dominant arm, according to the procedures described by Lohman et al. [18]. For bed-restricted patients, we obtained knee height, calf circumference, and non-dominant subscapular skinfold and mid-upper arm circumference measurements as previously described [19,20] and we estimated weight and height using the formulas of Chumlea et al. [20,21]. In addition, we measured tricipital skinfold of the non-dominant arm, according to previously described procedures [19]. To measure circumferences, skinfold thickness and knee height, we used an inelastic measuring tape of 1 mm precision, adipometer skinfold calipers (Lange Beta Technology Inc.; Santa Cruz, CA, USA) and an anthropometer (Fami Ita Products; Sao ? Caetano do Sul, Brazil), respectively. We measured skinfold thickness in duplicate from which we calculated a mean skinfold thickness. When the difference between the observed skinfold thickness was greater than 1 mm, we performed a third measurement and calculated the mean between the two closest measurements. We calculated body mass index (BMI) by dividing patient weight in kilograms by the square of patient height in meters and we applied the World Health Organization criteria of BMI ,18.5 kg/m2 to classify patients as malnourished [22]. We estimated the percentage of body weight loss based on the weight at hospital admission and the patient’s self-reported weight of six months prior to this hospitalization. The mid-upper arm circumference and the tricipital skinfold thickness were used to calculate the mid-upper arm muscle area with a correction for the bone area [23].Methods Study Design and ParticipantsWe conducted a cross-sectional study at the reference hospital for infectious diseases in Salvador, the third largest city in Brazil (2,480,790 inhabitants) [15], between June 2009 and March 2010. The 101-bed state hospital is one of three public health institutions providing specialized inpatient care for patients with AIDS in Salvador and it accounted for 32 of citywide AIDS hospitalizations during the study period [16]. Using an estimated prevalence of AZP-531 biological activity malnutrition of 50 , we determined our target sample size (n = 118) to achieve a precision of +/28 around the measured prevalence of malnutrition. This figure was based on the expected number of AIDS-related hospitalizations in persons 20 to 59 years of age in Salvador in 2008 [16]. We recruited participants by reviewing hospital registries five days a week and consecutively enrolling all patients from 20 to 59 years of age who: 1) were admitted to the hospital with a known diagnosis of AIDS, or 2) demonstrated serological AZP-531 price evidence of HIV infection with a rapid test (DPP HIV 1/2; BioManguinhos, Rio de Janeiro, Brazil) and met the U.S. Centers for Disease Control and Prevention (CDC) definition for AIDS in the first seven days of hospitalization [17]. Patients were ineligible for study entry if they required urgent intensive care support or if they were cognitively impaired and unaccompanied by a legal representative to provide informed consent. Patients with repeated hospitalizations during the study period were enrolled in the study only once. Patients diagnosed with AIDS after the seventh day of hospitalization were also ineligible for study entry because nutritional evaluation at that time could be unrepresentative of nutritional status at hospital admiss.Tadiometer (Seca Leicester; Hamburg, Germany). We also measured mid-upper arm circumference and tricipital skinfold of the non-dominant arm, according to the procedures described by Lohman et al. [18]. For bed-restricted patients, we obtained knee height, calf circumference, and non-dominant subscapular skinfold and mid-upper arm circumference measurements as previously described [19,20] and we estimated weight and height using the formulas of Chumlea et al. [20,21]. In addition, we measured tricipital skinfold of the non-dominant arm, according to previously described procedures [19]. To measure circumferences, skinfold thickness and knee height, we used an inelastic measuring tape of 1 mm precision, adipometer skinfold calipers (Lange Beta Technology Inc.; Santa Cruz, CA, USA) and an anthropometer (Fami Ita Products; Sao ? Caetano do Sul, Brazil), respectively. We measured skinfold thickness in duplicate from which we calculated a mean skinfold thickness. When the difference between the observed skinfold thickness was greater than 1 mm, we performed a third measurement and calculated the mean between the two closest measurements. We calculated body mass index (BMI) by dividing patient weight in kilograms by the square of patient height in meters and we applied the World Health Organization criteria of BMI ,18.5 kg/m2 to classify patients as malnourished [22]. We estimated the percentage of body weight loss based on the weight at hospital admission and the patient’s self-reported weight of six months prior to this hospitalization. The mid-upper arm circumference and the tricipital skinfold thickness were used to calculate the mid-upper arm muscle area with a correction for the bone area [23].Methods Study Design and ParticipantsWe conducted a cross-sectional study at the reference hospital for infectious diseases in Salvador, the third largest city in Brazil (2,480,790 inhabitants) [15], between June 2009 and March 2010. The 101-bed state hospital is one of three public health institutions providing specialized inpatient care for patients with AIDS in Salvador and it accounted for 32 of citywide AIDS hospitalizations during the study period [16]. Using an estimated prevalence of malnutrition of 50 , we determined our target sample size (n = 118) to achieve a precision of +/28 around the measured prevalence of malnutrition. This figure was based on the expected number of AIDS-related hospitalizations in persons 20 to 59 years of age in Salvador in 2008 [16]. We recruited participants by reviewing hospital registries five days a week and consecutively enrolling all patients from 20 to 59 years of age who: 1) were admitted to the hospital with a known diagnosis of AIDS, or 2) demonstrated serological evidence of HIV infection with a rapid test (DPP HIV 1/2; BioManguinhos, Rio de Janeiro, Brazil) and met the U.S. Centers for Disease Control and Prevention (CDC) definition for AIDS in the first seven days of hospitalization [17]. Patients were ineligible for study entry if they required urgent intensive care support or if they were cognitively impaired and unaccompanied by a legal representative to provide informed consent. Patients with repeated hospitalizations during the study period were enrolled in the study only once. Patients diagnosed with AIDS after the seventh day of hospitalization were also ineligible for study entry because nutritional evaluation at that time could be unrepresentative of nutritional status at hospital admiss.
http://cathepsin-s.com
Cathepsins
